New Oral-B toothpaste
February 8, 2013
PROCTER & Gamble’s Oral-B
brand has this month launched a
“revolutionary new therapeutic
toothpaste” in Australia which
uniquely combines stabilised
stannous flouride and sodium
polymetaphosphate.
Oral-B says the new Pro-Health
product is a “scientific
breakthrough” because it’s the first
time that stannous fluoride has been
able to be combined with other
ingredients in a stabilised form.
It’s been the subject of more than
70 studies, with key findings
indicating up to 96% reduction in
surface staining after two weeks of
use; up to 42% reduction in enamel
loss versus ordinary fluoride
toothpaste after 15 days; up to 71%
reduction in bad breath after three
weeks; up to 57% less gingival
bleeding after six months; and up
to 56% greater tartar inhibition.
The company said that given the
significance of the breakthrough,
P&G plans to drive interest through
a significant marketing investment.
“For pharmacists, this represents
a unique opportunity to grow frontof-
shop sales while building
pharmacy’s reputation as a
destination for oral care advice and
education,” said P&G Brand
Manager - Oral Care, Joel Cotter.
Oral-B Pro-Health is available
now, and will be distributed via
supermarkets as well as pharmacies.
The above article was sent to subscribers in Pharmacy Daily's issue from 08 Feb 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Feb 13
